There are 2789 resources available
638P - Evaluating the contribution of virtual peer-led support to comprehensive prostate cancer (PCa) care: The AnCan experience
Presenter: Herbert Geller
Session: ePoster Display
640TiP - Phase Ib/II trial of pembrolizumab (pembro) + lenvatinib combination therapy in patients (pts) with adenocarcinoma metastatic castration-resistant prostate cancer (mCRPC) or treatment-emergent neuroendocrine mCRPC (t-NE): KEYNOTE-365 cohorts E and F
Presenter: Gero Kramer
Session: ePoster Display
136P - Assessment of sentinel lymph node biopsy versus axillary lymph node dissection on long-term survival in breast cancer patients with pathologically negative lymph node
Presenter: Shusen Wang
Session: ePoster Display
137P - Trial comparing the safety, efficacy and immunogenicity of trastuzumab biosimilar candidate (TX05) with originator trastuzumab in HER2+ early breast cancer
Presenter: Peter Krivorotko
Session: ePoster Display
139P - HER2+/HR+ breast cancer patients at high risk of relapse derive benefit from extended adjuvant treatment with neratinib: An exploratory analysis from ExteNET study
Presenter: Francesco Cognetti
Session: ePoster Display
140P - Benefit of adjuvant chemotherapy in luminal A-like early breast cancer in women aged 40 years or younger: Results of a national multi-institutional study
Presenter: Ondine Dufour
Session: ePoster Display
141P - Gene-expression pathways and dynamics during neoadjuvant chemo-free therapy predict pathologic complete response in ER+/HER2+ breast cancer (BC)
Presenter: Matteo Dugo
Session: ePoster Display